Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13
Clinical Trial Report
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Dose–response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,113 | Dovepress* | 7,300+ | 1,474 | 8,774 | |
PubMed Central* | 813 | 221 | 1,034 | ||
Totals | 8,113 | 1,695 | 9,808 | ||
*Since 25 May 2018 |
View citations on PubMed Central and Google Scholar